{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:45:05Z","timestamp":1792651505099,"version":"4.5.0"},"reference-count":39,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL138190"],"award-info":[{"award-number":["K23HL138190"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2022,11,23]]},"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>A genomic classifier for usual interstitial pneumonia (gUIP) has been shown to predict histological UIP with high specificity, increasing diagnostic confidence for idiopathic pulmonary fibrosis (IPF). Whether those with positive gUIP classification exhibit a progressive, IPF-like phenotype remains unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A pooled, retrospective analysis of patients who underwent clinically indicated diagnostic bronchoscopy with gUIP testing at seven academic medical centres across the USA was performed. We assessed the association between gUIP classification and 18-month progression-free survival (PFS) using Cox proportional hazards regression. PFS was defined as the time from gUIP testing to death from any cause, lung transplant, \u226510% relative decline in forced vital capacity (FVC) or censoring at the time of last available FVC measure. Longitudinal change in FVC was then compared between gUIP classification groups using a joint regression model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 238 consecutive patients who underwent gUIP testing, 192 had available follow-up data and were included in the analysis, including 104 with positive gUIP classification and 88 with negative classification. In multivariable analysis, positive gUIP classification was associated with reduced PFS (hazard ratio 1.58, 95% CI 0.86\u20132.92; p=0.14), but this did not reach statistical significance. Mean annual change in FVC was \u2212101.8\u2005mL (95% CI \u2212142.7\u2013\u2009\u221260.9\u2005mL; p&lt;0.001) for those with positive gUIP classification and \u221273.2\u2005mL (95% CI \u2212115.2\u2013\u2009\u221231.1\u2005mL; p&lt;0.001) for those with negative classification (difference 28.7\u2005mL, 95% CI \u221283.2\u201325.9\u2005mL; p=0.30).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>gUIP classification was not associated with differential rates of PFS or longitudinal FVC decline in a multicentre interstitial lung disease cohort undergoing bronchoscopy as part of the diagnostic evaluation.<\/jats:p><\/jats:sec>","DOI":"10.1183\/13993003.01245-2022","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T13:00:14Z","timestamp":1671714014000},"page":"2201245","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Interstitial lung disease progression after genomic usual interstitial pneumonia testing"],"prefix":"10.1183","volume":"61","author":[{"given":"Sachin","family":"Chaudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Sam","family":"Weigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel L.","family":"Ribeiro Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan S.","family":"Benn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8889-2757","authenticated-orcid":false,"given":"Janelle Vu","family":"Pugashetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Keith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arista","family":"Chand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayez","family":"Kheir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richart","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Lasky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin M.","family":"Oldham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"2024102103100754000_61.4.2201245.1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201612-947OC"},{"key":"2024102103100754000_61.4.2201245.2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S2213-2600(19)30059-1","article-title":"Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study","volume":"7","author":"Raghu","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024102103100754000_61.4.2201245.3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1164\/rccm.202003-0877OC","article-title":"Utility of a molecular classifier as a complement to HRCT to identify usual interstitial pneumonia","volume":"203","author":"Richeldi","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103100754000_61.4.2201245.4","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.chest.2020.05.532","article-title":"Using bronchoscopic lung cryobiopsy and a genomic classifier in the multidisciplinary diagnosis of diffuse interstitial lung diseases","volume":"158","author":"Kheir","year":"2020","journal-title":"Chest"},{"key":"2024102103100754000_61.4.2201245.5","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1513\/AnnalsATS.202107-897OC","article-title":"The impact of the Envisia genomic classifier in the diagnosis and management of patients with idiopathic pulmonary fibrosis","volume":"19","author":"Lasky","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2024102103100754000_61.4.2201245.6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST"},{"key":"2024102103100754000_61.4.2201245.7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00357-2015"},{"key":"2024102103100754000_61.4.2201245.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.08.1076"},{"key":"2024102103100754000_61.4.2201245.9","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00131912"},{"key":"2024102103100754000_61.4.2201245.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61079-4"},{"key":"2024102103100754000_61.4.2201245.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.10.029"},{"key":"2024102103100754000_61.4.2201245.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113354"},{"key":"2024102103100754000_61.4.2201245.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402582"},{"key":"2024102103100754000_61.4.2201245.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584"},{"key":"2024102103100754000_61.4.2201245.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"2024102103100754000_61.4.2201245.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2018-000289"},{"key":"2024102103100754000_61.4.2201245.17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","article-title":"Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper","volume":"6","author":"Lynch","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024102103100754000_61.4.2201245.18","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201910-1915OC","article-title":"Risk factors for acute rejection in the first year after lung transplant. A multicenter study","volume":"202","author":"Todd","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103100754000_61.4.2201245.19","doi-asserted-by":"publisher","DOI":"10.1111\/insr.12214"},{"key":"2024102103100754000_61.4.2201245.20","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5644"},{"key":"2024102103100754000_61.4.2201245.21","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19970215)16:3<259::AID-SIM484>3.0.CO;2-S"},{"key":"2024102103100754000_61.4.2201245.22","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01396-2021"},{"key":"2024102103100754000_61.4.2201245.23","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.152"},{"key":"2024102103100754000_61.4.2201245.24","first-page":"193","article-title":"Asbestosis and environmental causes of usual interstitial pneumonia","volume":"21","author":"Gulati","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"2024102103100754000_61.4.2201245.25","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2106012"},{"key":"2024102103100754000_61.4.2201245.26","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0053"},{"key":"2024102103100754000_61.4.2201245.27","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.6.2019"},{"key":"2024102103100754000_61.4.2201245.28","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.5.1489"},{"key":"2024102103100754000_61.4.2201245.29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S2213-2600(20)30554-3","article-title":"Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Behr","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2024102103100754000_61.4.2201245.30","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"2024102103100754000_61.4.2201245.31","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2214\/AJR.16.17121","article-title":"CT findings, radiologic-pathologic correlation, and imaging predictors of survival for patients with interstitial pneumonia with autoimmune features","volume":"208","author":"Chung","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"2024102103100754000_61.4.2201245.32","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2214\/AJR.17.18947","article-title":"CT-pathologic correlation of major types of pulmonary fibrosis: insights for revisions to current guidelines","volume":"210","author":"Chung","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"2024102103100754000_61.4.2201245.33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S2213-2600(14)70011-6","article-title":"Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial","volume":"2","author":"Raghu","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2024102103100754000_61.4.2201245.34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1164\/rccm.201602-0402OC","article-title":"Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria","volume":"195","author":"Raghu","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103100754000_61.4.2201245.35","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202005-2032ST"},{"key":"2024102103100754000_61.4.2201245.36","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202002-0251ST"},{"key":"2024102103100754000_61.4.2201245.37","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200211-1311OC"},{"key":"2024102103100754000_61.4.2201245.38","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00155108"},{"key":"2024102103100754000_61.4.2201245.39","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1513\/AnnalsATS.202007-901OC","article-title":"Adoption of the antifibrotic medications pirfenidone and nintedanib for patients with idiopathic pulmonary fibrosis","volume":"18","author":"Dempsey","year":"2021","journal-title":"Ann Am Thorac Soc"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01245-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:12:27Z","timestamp":1740377547000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01245-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,1]]},"published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1183\/13993003.01245-2022"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01245-2022","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]}}}